SCHEMBL24716035

SCHEMBL24716035

COCCn1c2c(cc(Nc3ncc(Cl)c(Nc4ccccc4P(C)(C)=O)n3)c1=O)CCN(C)C2

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 15/20 0.68
▸ INSR P06213 5/20 0.58
▸ IGF1R P08069 5/20 0.58
▸ ALK Q9UM73 5/20 0.58
▸ CHEK1 O14757 1/20 0.56
▸ AURKA O14965 1/20 0.56
▸ NUAK1 O60285 1/20 0.56
▸ JAK2 O60674 1/20 0.56
▸ STK10 O94804 1/20 0.56
▸ PRKD3 O94806 1/20 0.56
▸ SLC34A2 O95436 1/20 0.56
▸ CHEK2 O96017 1/20 0.56
▸ ABL1 P00519 1/20 0.56
▸ EGFR P00533 1/20 0.56
▸ CD74 P04233 1/20 0.56
▸ ERBB2 P04626 1/20 0.56
▸ LCK P06239 1/20 0.56
▸ FYN P06241 1/20 0.56
▸ FES P07332 1/20 0.56
▸ CSF1R P07333 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24715916 0.94 MAP4K1 (0.71) MAP4K1INSRIGF1RALKCHEK1
SCHEMBL24716031 0.88 MAP4K1 (0.71) MAP4K1INSRIGF1RALKEGFR
SCHEMBL24715910 0.86 MAP4K1 (0.68) MAP4K1INSRIGF1RALKEGFR
SCHEMBL24716364 0.84 MAP4K1 (0.68) MAP4K1INSRIGF1RALK
SCHEMBL24715921 0.84 MAP4K1 (0.72) MAP4K1INSRIGF1RALKEGFR
SCHEMBL24715912 0.83 MAP4K1 (0.72) MAP4K1INSRIGF1RALKEGFR
SCHEMBL20214787 0.82 MAP4K1 (0.84) MAP4K1INSRIGF1RALKEGFR
SCHEMBL24039985 0.82 MAP4K1 (0.84) MAP4K1INSRIGF1RALKEGFR
SCHEMBL24040082 0.81 MAP4K1 (1.00) MAP4K1INSRIGF1RALK
SCHEMBL20214415 0.81 MAP4K1 (1.00) MAP4K1INSRIGF1RALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022214008-A1 HIGHLY ACTIVE HPK1 KINASE INHIBITOR 杭州阿诺生物医药科技有限公司 2022-10-13 — — WO disclosed
Send feedback